Kintsugi, a Techstars UHC Accelerator portfolio company, is developing smarter mental healthcare. We provide talk therapy software to users in over 250 international cities, and as a result of collecting the world's largest longitudinal, annotated voice data for machine learning, we've created the first clinical-grade voice biomarker diagnostic (U.S. Patent-Pending and FDA De Novo pending) to measure the severity of depression and anxiety in real-time. Voice detects a variety of health conditions, emotions, and diseases. Voice biomarkers allow us to predict the existence of disease, monitor progression or deterioration of disease or chronic condition, predict hospitalization and mortality, focus on patients in need, and as a result, optimize care and cost. We are truly excited to scale mental health with smart software during and post virtual appointments. We believe the future of medicine will be in the comfort of our homes. To learn more: https://www.kintsugihello.com
Is this your company?
Inaccurate data? Flag it here.
